| Source: |
| Type: |
| A protein reported to play an important role in sensitizing cancer cells to apoptosis.
Death Receptor 5 (DR5), also known as TRAIL receptor 2, is a member of the tumor necrosis factor (TNF) receptor superfamily. It plays a crucial role in the apoptosis (programmed cell death) pathway, particularly in the context of cancer. DR5 is often overexpressed in various types of tumors, including breast, colon, and lung cancers. This overexpression can make cancer cells more susceptible to TRAIL-induced apoptosis. |
| Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system, accounting for 80–90% of kidney neoplasms. The activation of the mTOR pathway has been found in RCC and is correlated with high grade and poor prognostic patient features (41,42). |
| 2855- | FIS, | DR5_Expression_in_Human_Renal_Carcinoma_Caki_Cells">Fisetin Induces Apoptosis Through p53-Mediated Up-Regulation of DR5 Expression in Human Renal Carcinoma Caki Cells |
| - | in-vitro, | RCC, | Caki-1 |
| 794- | GAR, | Garcinol Enhances TRAIL-Induced Apoptotic Cell Death through Up-Regulation of DR5 and Down-Regulation of c-FLIP Expression |
| - | in-vitro, | RCC, | NA | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:24 Cells:% prod#:% Target#:88 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid